100s of titles, one news app for just $10 a month.
Dive Deeper:
Regulus Therapeutics: Q1 Earnings Insights
Regulus Therapeutics (NASDAQ:RGLS) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need…
Orchard Therapeutics Earnings Preview
Orchard Therapeutics (NASDAQ:ORTX) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to…
Preview: Virios Therapeutics's Earnings
Virios Therapeutics (NASDAQ:VIRI) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to…
Onconova Therapeutics Earnings Preview
Onconova Therapeutics (NASDAQ:ONTX) is set to give its latest quarterly earnings report on Wednesday, 2022-05-11. Here's what investors need to…
One subscription that gives you access to news from hundreds of sites
Earnings Preview: Lineage Cell Therapeutics
Lineage Cell Therapeutics (AMEX:LCTX) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need…
A Preview Of icad's Earnings
icad (NASDAQ:ICAD) is set to give its latest quarterly earnings report on Wednesday, 2022-05-11. Here's what investors need to know…
Get all your news in one place
Latest Business news:
Fraud alert! AI identifies the four stages of a scam phone call
Australian researchers have used machine learning techniques to identify the typical four stages of fraudulent money-taking phone calls.
Read news from The Economist, FT, Bloomberg and more, with one subscription
Learn More
The Stats Guy: What does tourism in Australia look like now that travellers are returning?
The tourism sector is preparing for a comeback. So, what is the state of play in the sector and what…
Mining companies back away from Brazil's Indigenous areas
Some of the world’s biggest mining companies have withdrawn requests to research and extract minerals on Indigenous land in Brazil’s…
Yellen's global tax plan meets resistance abroad and at home
Last July, Treasury Secretary Janet Yellen celebrated it as a “historic day” when more than 100 nations agreed to a…
‘The rich have got much richer’: why art sale prices are going through the roof
Auction houses are recording a boom in sales after a return to pre-pandemic levels of supplies of works
From analysis to good news, read the world’s best news in one place
Japan, Europe tread different paths as G7 warns of inflation risks
Having long trod a similar path in tackling low inflation, Japan and Europe now appear to be taking contrasting approaches…
Just 10 weeks’ worth of wheat in global stockpile, UN warned
The world has only 10 weeks’ worth of wheat stockpiled after Vladimir Putin’s invasion of Ukraine disrupted supplies from the…

Earnings Preview: Regulus Therapeutics

By Benzinga Insights

Regulus Therapeutics (NASDAQ:RGLS) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement.

Analysts estimate that Regulus Therapeutics will report an earnings per share (EPS) of $-0.05.

Regulus Therapeutics bulls will hope to hear the company to announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Past Earnings Performance

Last quarter the company missed EPS by $0.00, which was followed by a 5.63% drop in the share price the next day.

Here's a look at Regulus Therapeutics's past performance and the resulting price change:

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -0.07 -0.08 -0.08 -0.09
EPS Actual -0.07 -0.10 -0.08 -0.08
Price Change % -5.63% -3.98% -3.85% 7.32%

Stock Performance

Shares of Regulus Therapeutics were trading at $0.1718 as of May 10. Over the last 52-week period, shares are down 67.43%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.

To track all earnings releases for Regulus Therapeutics visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

What is inkl?
The world’s most important news, from 100+ trusted global sources, in one place.
Morning Edition
Your daily
news overview

Morning Edition ensures you start your day well informed.

No paywalls, no clickbait, no ads
Enjoy beautiful reading

Content is only half the story. The world's best news experience is free from distraction: ad-free, clickbait-free, and beautifully designed.

Expert Curation
The news you need to know

Stories are ranked by proprietary algorithms based on importance and curated by real news journalists to ensure that you receive the most important stories as they break.

Dive Deeper:
Regulus Therapeutics: Q1 Earnings Insights
Regulus Therapeutics (NASDAQ:RGLS) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need…
Orchard Therapeutics Earnings Preview
Orchard Therapeutics (NASDAQ:ORTX) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to…
Preview: Virios Therapeutics's Earnings
Virios Therapeutics (NASDAQ:VIRI) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to…
Onconova Therapeutics Earnings Preview
Onconova Therapeutics (NASDAQ:ONTX) is set to give its latest quarterly earnings report on Wednesday, 2022-05-11. Here's what investors need to…
One subscription that gives you access to news from hundreds of sites
Earnings Preview: Lineage Cell Therapeutics
Lineage Cell Therapeutics (AMEX:LCTX) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need…
A Preview Of icad's Earnings
icad (NASDAQ:ICAD) is set to give its latest quarterly earnings report on Wednesday, 2022-05-11. Here's what investors need to know…
Get all your news in one place